Fincanna Capital Corp
CNSX:CALI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fincanna Capital Corp
CNSX:CALI
|
CA |
|
Riedel Resources Ltd
ASX:RIE
|
AU |
|
S
|
Surgepays Inc
NASDAQ:SURG
|
US |
|
Reitmans Canada Ltd
F:CX40
|
CA |
|
C
|
Coeur Mining Inc
F:CDM1
|
US |
|
A
|
AP Moeller - Maersk A/S
DUS:DP4B
|
DK |
|
Boeing Co
NYSE:BA
|
US |
|
G
|
GT Biopharma Inc
F:OXI
|
US |
|
D
|
Devon Energy Corp
XBER:DY6
|
US |
|
Golden Minerals Co
TSX:AUMN
|
US |
|
F
|
Franklin Resources Inc
DUS:FRK
|
US |
|
V
|
Vidis SA
WSE:VDS
|
PL |
|
Fabasoft AG
F:FAA
|
AT |
|
Tesoro Minerals Corp
XTSX:TES
|
CA |
|
B
|
Buru Energy Ltd
F:BUD
|
AU |
|
G
|
Gear Energy Ltd
OTC:GENGF
|
CA |
|
Sonae SGPS SA
F:YSON
|
PT |
Bankruptcy Probability
Fincanna Capital Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Fincanna Capital Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
F
|
Fincanna Capital Corp
CNSX:CALI
|
338.1k CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Fincanna Capital Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Fincanna Capital Corp has no debt.
You can find a full breakdown on its Balance Sheet.
